The medication rate for ACE inhibitors or ARBs within three months of discharge for patients with acute myocardial infarction (AMI) - (indicator by disease)
The Health Insurance Agency has selected evidence-based medical indicators to be made public in order to enhance the quality of medical care for patients with myocardial infarction. These indicators will serve as references for related diseases and healthcare quality when seeking medical treatment. The public indicators are divided into three categories based on the treatment period and quality aspects, including process evaluation during hospitalization, evaluation of continuous drug therapy upon discharge, and outcome evaluation. This includes the ratio of AMI patients undergoing LDL lipid tests during hospitalization, medication ratios for AMI patients during hospitalization and within three, six, and nine months after discharge, emergency room revisit ratios within three days after discharge for the same main diagnosis or related conditions, and unplanned readmission ratios within fourteen days after discharge for the same main diagnosis or related conditions.
Data fields
Year、Medical institution code、Name of medical institution、Special Category、The number of patients who were prescribed ACEI or ARB at the same hospital outpatient clinic within 3 months after discharge from the denominator cases.、Discharged AMI case_ Exclude Hypotension、The ratio of ACE inhibitor or ARB given within 3 months after discharge、The number of attending physicians reported、Average patient age、The number of seriously ill patients、The ratio of critically ill patients.、County/City、Township/City Classification
Contact person
陳綉琴 (02-27065866#3006)
Update frequency
Every June
License
Open Government Data License, version 1.0
Charge
free
Publish date
2015-11-23
Dataset type
System programming interface
Updated time
2025-06-01 10:50
Topic
Other
Service category
Dataset Category
Data archives
Keyword
Medical qualityAcute myocardial infarction.AMIAngiotensin-converting enzyme inhibitorsACEinhibitorAngiotensin II receptor blockersARB
Note
Authorization explanation URL: https://data.nhi.gov.tw/Banner/DevelopGuide.aspxAPI documentation for OAS standard: https://data.nhi.gov.tw/openapi.jsonThis dataset resource ID: A21030000I-E32017-001
Related datasets
- The medication rate for ACE inhibitors or ARBs for patients with acute myocardial infarction (AMI) discharged within six months (Disease-specific indicator)
- The rate of administration of ACE inhibitors or ARBs to patients with acute myocardial infarction (AMI) during hospitalization (disease-specific indicator)
- The rate of the prescription of angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin II receptor blockers (ARBs) within nine months of discharge for acute myocardial infarction (AMI) patients.
- The rate of medication given within six months after discharge for patients with acute myocardial infarction (AMI) - aspirin (disease-specific indicator)
- Acute myocardial infarction (AMI) patient medication rate during hospitalization - Aspirin (Disease-specific indicator)
Applications
No available applications